Row:(In millions, except per share amounts)
			Row:Operating revenue 	$ 3,412.1 	$ 3,362.2 	$ 3,144.9
Row:Operating expenses:
			Row:Cost of services (exclusive of depreciation and amortization below) 	1,440.4 	1,210.7 	1,113.4
Row:Selling, general and administrative expenses 	1,213.3 	1,032.0 	941.0
Row:Depreciation and amortization 	310.4 	287.8 	265.4
Row:Total operating expenses 	2,964.1 	2,530.5 	2,319.8
Row:Operating income 	448.0 	831.7 	825.1
Row:Interest expense 	(103.5) 	(92.8) 	(92.1)
Row:Other income (expense), net 	11.8 	7.7 	(4.8)
Row:Consolidated income before income taxes 	356.3 	746.6 	728.2
Row:Provision for income taxes 	(50.0) 	(148.6) 	(233.1)
Row:Consolidated net income 	306.3 	598.0 	495.1
Row:Less: Net income attributable to noncontrolling interests including
redeemable noncontrolling interests 	(6.5) 	(10.7) 	(6.3)
Row:Net income attributable to Equifax 	$ 299.8 	$ 587.3 	$ 488.8
Row:Basic earnings per common share:
			Row:Net income attributable to Equifax 	$ 2.49 	$ 4.89 	$ 4.10
Row:Weighted-average shares used in computing basic earnings per share 	120.4 	120.1 	119.3
Row:Diluted earnings per common share:
			Row:Net income attributable to Equifax 	$ 2.47 	$ 4.83 	$ 4.04
Row:Weighted-average shares used in computing diluted earnings per share 	121.4 	121.5 	121.1
Row:Dividends per common share 	$ 1.56 	$ 1.56 	$ 1.32
Row:2018 	2017
Row:ASSETS
			Row:Current assets:
			Row:Cash and cash equivalents 	$ 	223.6 	$ 336.4
Row:Trade accounts receivable, net of allowance for doubtful accounts of $10.9 and $9.1 at
December 31, 2018 and 2017, respectively 		469.1 	444.8
Row:Prepaid expenses 		100.0 	94.3
Row:Other current assets Total current assets 		109.6 902.3 	122.9
998.4
Row:Property and equipment:
			Row:Capitalized internal-use software and system costs 		684.1 	427.9
Row:Data processing equipment and furniture 		344.6 	306.6
Row:Land, buildings and improvements 		216.1 	212.5
Row:Total property and equipment 		1,244.8 	947.0
Row:Less accumulated depreciation and amortization 		(480.0) 	(380.0)
Row:Total property and equipment, net 		764.8 	567.0
Row:Goodwill 		4,129.7 	4,184.0
Row:Indefinite-lived intangible assets 		94.8 	95.0
Row:Purchased intangible assets, net 		1,099.2 	1,247.0
Row:Other assets, net 		162.4 	142.0
Row:Total assets 	$ 	7,153.2 	$ 7,233.4
Row:LIABILITIES AND EQUITY
			Row:Current liabilities:
			Row:Short-term debt and current maturities of long-term debt 	$ 	4.9 	$ 965.3
Row:Accounts payable 		175.7 	110.3
Row:Accrued expenses 		213.2 	160.9
Row:Accrued salaries and bonuses 		131.0 	119.4
Row:Deferred revenue 		98.0 	108.4
Row:Other current liabilities 		204.0 	209.2
Row:Total current liabilities 		826.8 	1,673.5
Row:Long-term debt 		2,630.6 	1,739.0
Row:Deferred income tax liabilities, net 		316.2 	305.1
Row:Long-term pension and other postretirement benefit liabilities Other long-term liabilities Total liabilities Commitments and Contingencies (see Note 6)
Equifax shareholders’ equity:
Preferred stock, $0.01 par value: Authorized shares - 10.0; Issued shares - none 		139.3 84.6 3,997.5 — 	175.8
101.0
3,994.4
—
Row:Preferred stock, $0.01 par value: Authorized shares - 10.0; Issued shares - none 	— 	—
Row:Common stock, $1.25 par value: Authorized shares - 300.0;
Issued shares - 189.3 at December 31, 2018 and 2017;
Outstanding shares - 120.6 and 120.1 at December 31, 2018 and 2017, respectively 	236.6 	236.6
Row:Paid-in capital 	1,356.6 	1,332.7
Row:Retained earnings 	4,717.8 	4,600.6
Row:Accumulated other comprehensive loss 	(626.3) 	(412.0)
Row:Treasury stock, at cost, 68.1 shares and 68.6 shares at December 31, 2018 and 2017,
respectively 	(2,571.0) 	(2,577.6)
Row:Stock held by employee benefits trusts, at cost, 0.6 shares at December 31, 2018 and 2017 	(5.9) 	(5.9)
Row:Total Equifax shareholders’ equity 	3,107.8 	3,174.4
Row:Noncontrolling interests including redeemable noncontrolling interests 	47.9 	64.6
Row:Total shareholders’ equity 	3,155.7 	3,239.0
Row:Total liabilities and equity $ 	7,153.2 	$ 7,233.4
Row:See Notes to Consolidated Financial Statements.
		Row:(In millions)
Operating activities:
			Row:Consolidated net income $ 	306.3 	$ 598.0 	$ 495.1
Row:Adjustments to reconcile consolidated net income to net cash provided by
operating activities:
			Row:Depreciation and amortization 	315.9 	290.9 	268.7
Row:Stock-based compensation expense 	42.5 	38.3 	37.1
Row:Excess tax benefits from stock-based compensation plans Deferred income taxes Changes in assets and liabilities, excluding effects of acquisitions:
Accounts receivable, net Other assets, current and long-term 	— (2.3) (37.4) (15.4) 	— (44.1) (1.3) (120.1) 	(35.9)
(13.0)
(55.7)
0.3
Row:Current and long-term liabilities, excluding debt Cash provided by operating activities 	62.6 672.2 	54.3 816.0 	126.4
823.0
Row:Investing activities:
			Row:Capital expenditures Acquisitions, net of cash acquired Cash received from sale of asset 	(321.9) (138.3) 5.6 	(218.2) (139.9) 8.6 	(173.5)
(1,791.6)
—
Row:Economic hedges 	— 	— 	(10.8)
Row:Investment in unconsolidated affiliates, net 	(6.9) 	— 	—
Row:Cash used in investing activities 	(461.5) 	(349.5) 	(1,975.9)
Row:Financing activities:
			Row:Net short-term borrowings (repayments) 	(959.2) 	252.4 	73.0
Row:Payments on long-term debt Proceeds from issuance of long-term debt Treasury stock purchases 	(100.0) 994.5 — 	(322.5) 100.0 (77.1) 	(350.0)
1,574.7
—
Row:Dividends paid to Equifax shareholders 	(187.9) 	(187.4) 	(157.6)
Row:Dividends paid to noncontrolling interests 	(10.3) 	(8.4) 	(5.8)
Row:Proceeds from exercise of stock options 	11.8 	19.2 	31.5
Row:Payment of taxes related to settlement of equity awards 	(19.7) 	(33.5) 	(27.2)
Row:Excess tax benefits from stock-based compensation plans 	— 	— 	35.9
Row:Payment of contingent consideration 	(1.5) 	(3.5) 	(4.4)
Row:Purchase of redeemable noncontrolling interests 	(30.9) 	(2.6) 	(3.6)
Row:Debt issuance costs 	(7.8) 	(0.3) 	(6.2)
Row:Cash (used in) provided by financing activities 	(311.0) 	(263.7) 	1,160.3
Row:Effect of foreign currency exchange rates on cash and cash equivalents 	(12.5) 	4.3 	28.6
Row:Increase (decrease) in cash and cash equivalents 	(112.8) 	207.1 	36.0
Row:Cash and cash equivalents, beginning of period 	336.4 	129.3 	93.3
Row:Cash and cash equivalents, end of period $ 	223.6 	$ 336.4 	$ 129.3
Row:See Notes to Consolidated Financial Statements.
			